Primary ILM peeling prevents macula pucker development

Article

Primary peeling of the internal limiting membrane (ILM) successfully prevents the development of macula pucker and the full removal of all epiretinal membranes.

Primary peeling of the internal limiting membrane (ILM) successfully prevents the development of macula pucker and the full removal of all epiretinal membranes, claims a study in the journal Retina.

The investigation, led by Dr D. Odrobina, Klinika Okulistyczna, Poland, included of 84 patients who underwent retinectomy with silicone oil tamponade for retinal detachment caused by proliferative vitreoretinopathy.

Eyes were split into two groups with 33 eyes in group A and 51 eyes in group B. In group A the ILM was peeled and in group B the ILM was not peeled. The effect of ILM peeling for the prevention of macula pucker was determined by slit-lamp examination.

The first month after retinectomy revealed cases of extramacular epiretinal cellular proliferation in 3 eyes in group A and 3 eyes in group B. In the final follow-up there were no macular pucker cases in group A and 9 cases of macula pucker in group B.

Eyes with retinal detachment caused by proliferative vitreoretinopathy were successfully treated by retinectomy and silicone oil tamponade. Primary peeling of the ILM is a successful method of preventing the development of macula pucker.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.